EUVIMEDEUVIMED entdecken
Crossref

Mesenchymal stem cell–derived exosomes derived from induced pluripotent stem cells ameliorate inflammation and promote mucosal healing via miR-34a-5p in Crohn disease

Ting Feng iD, Yun Qiu iD, Baili Chen, Xuanzhi Huang, Rui Feng, Yao He, Zhirong Zeng, Minhu Chen, Shenghong Zhang iD

Inflammatory Bowel Diseases · 01.05.2026 · 32 (5) · 852-868

DOI: 10.1093/ibd/izag014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 03.03.2026. Verfasst von Ting Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, P.R. China. Hauptthemen laut MEDLINE: Exosomes, MicroRNAs, Mesenchymal Stem Cells, Crohn Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Crohn disease (CD) is a chronic, recurrent inflammatory bowel disease. Mesenchymal stem cell–derived exosomes (MSC-Exos) have emerged as promising cell-free treatments for CD.

Objective

In this study we aimed to investigate the therapeutic effect and potential mechanisms of MSC-Exos derived from induced pluripotent stem cells (iPSCs) (iPSC–MSC-Exos) in patients with colitis. Methods iPSC–MSC-Exos were administered intraperitoneally to mice with trinitrobenzene sulfonic acid (TNBS)–induced colitis. The colonic stem cell markers Lgr5 and Bmi1, and the proliferation marker Ki-67 were assessed by immunofluorescence. Lamina propria mononuclear cells (LPMCs) were isolated from the mouse colons and analyzed by flow cytometry. Furthermore, microarray analysis was performed to identify the differential expression of micro RNAs (miRNAs) in the iPSC-MSC-Exos. iPSC-MSC-Exos with micro RNA (miR)-34a-5p overexpression (Exo-OE) or knockdown (Exo-KD) were used to treat colitis in the mice. The candidate targets of miR-34a-5p and its downstream signaling pathways were confirmed by quantitative reverse transcription–polymerase chain reaction (qRT-PCR) and Western blotting.

Results

The iPSC-MSC-Exos migrated to the inflamed colon and protected the colon stem cells against inflammatory damage, promoted epithelial cell proliferation, and decreased the infiltration of proinflammatory Th1/9/17, CD4 + tumor necrosis factor alpha (TNF-α)+, and macrophage cells while increasing anti-inflammatory T-regulatory (Treg) and B-regulatory (Breg) cells to alleviate TNBS-induced colitis in the mice. The therapeutic effect was sustained for 7 days after a single injection. MiR-34a-5p Exo-OE magnified this effect, whereas Exo-KD abolished it. The iPSC-MSC-Exos also inhibited the proliferation and migration of CD4 + LPMCs isolated from patients with CD. The miR-34a-5p expression was significantly elevated in the iPSC-MSC-Exos, which inhibited PPP2R3A expression by directly targeting its 3′ untranslated region (3′-UTR). MiR-34a-5p Exo-OE significantly decreased the expression of PPP2R3A while increasing the expression of the Wingless-related integration site (Wnt) signaling ligands of β-catenin (Wnt/β-catenin signaling) and CD44. Conclusions iPSC-MSC-Exos ameliorated colitis and promoted mucosal healing in a TNBS-induced CD-like model by activating Wnt/β-catenin signaling via miR-34a-5p, which targets PPP2R3A.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMicroRNAsMesenchymal Stem CellsCrohn DiseaseInduced Pluripotent Stem CellsIntestinal MucosaColitisInflammationAnimalsMiceHumansCell ProliferationMaleTrinitrobenzenesulfonic AcidMice, Inbred C57BLDisease Models, AnimalWound Healing

Stichwörter der Autor:innen

PPP2R3AWnt/β-catenin signalingcolitisexosomeiPSC-MSCsmiR-34a-5p

Substanzen

MicroRNAsMIRN34a microRNA, mouseTrinitrobenzenesulfonic Acid

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, P.R. China.
  • Department of Gastroenterology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, P.R. China.

ORCID-Profile: Ting Feng, Yun Qiu, Shenghong Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Feng, T., Qiu, Y., Chen, B., Huang, X., Feng, R., He, Y., Zeng, Z., Chen, M., & Zhang, S. (2026). Mesenchymal stem cell–derived exosomes derived from induced pluripotent stem cells ameliorate inflammation and promote mucosal healing via miR-34a-5p in Crohn disease. Inflammatory Bowel Diseases, 32(5), 852-868. https://doi.org/10.1093/ibd/izag014

Vancouver

Feng T, Qiu Y, Chen B, Huang X, Feng R, He Y, et al. Mesenchymal stem cell–derived exosomes derived from induced pluripotent stem cells ameliorate inflammation and promote mucosal healing via miR-34a-5p in Crohn disease. Inflammatory Bowel Diseases. 2026;32(5):852-868. doi:10.1093/ibd/izag014

BibTeX
@article{Feng2026,
  author = {Feng, Ting and Qiu, Yun and Chen, Baili and Huang, Xuanzhi and Feng, Rui and He, Yao and Zeng, Zhirong and Chen, Minhu and Zhang, Shenghong},
  title = {Mesenchymal stem cell–derived exosomes derived from induced pluripotent stem cells ameliorate inflammation and promote mucosal healing via miR-34a-5p in Crohn disease},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  volume = {32},
  number = {5},
  pages = {852--868},
  doi = {10.1093/ibd/izag014}
}
Kostenlos starten →